This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Rhode Island Board of Pharmacy | |
|---|---|
| Name | Rhode Island Board of Pharmacy |
| Type | Regulatory agency |
| Formed | 19th century |
| Jurisdiction | State of Rhode Island |
| Headquarters | Providence, Rhode Island |
| Parent agency | Rhode Island Department of Health |
| Website | (official) |
Rhode Island Board of Pharmacy is the state regulatory authority responsible for licensure, oversight, and discipline related to pharmacies, pharmacists, pharmacy technicians, and controlled substances within the State of Rhode Island. It interacts with federal entities, state departments, professional associations, and healthcare institutions to implement statutes and rules affecting medication distribution, public safety, and practitioner competence. The board’s activities intersect with legal decisions, public health initiatives, and national policy trends in pharmacy practice.
The board traces roots to 19th-century statutory reforms that paralleled developments in American Pharmacists Association, National Association of Boards of Pharmacy, Food and Drug Administration, United States Pharmacopeia, and state-level pharmacy acts enacted across Massachusetts, Connecticut, New York (state), New Jersey, and Pennsylvania. Early regulatory milestones were influenced by cases in Supreme Court of the United States, legislative models from Model State Pharmacy Act, and public health responses to epidemics like 1918 influenza pandemic. Mid-20th-century shifts, including the creation of Medicare, Medicaid, and the Controlled Substances Act, prompted revisions informed by advisory groups such as American Medical Association, American Society of Health-System Pharmacists, and Centers for Disease Control and Prevention. Contemporary history reflects engagement with reforms after events tied to opioid prescribing controversies investigated by Drug Enforcement Administration, litigated in United States District Court for the District of Rhode Island, and debated in the Rhode Island General Assembly.
The board’s composition aligns with statutory requirements enacted by the Rhode Island General Assembly and gubernatorial appointments confirmed through processes involving the Governor of Rhode Island and committees such as the Rhode Island Senate. Membership typically includes licensed pharmacists nominated by organizations like the Rhode Island Pharmacists Association and representatives with ties to institutions such as Brown University, University of Rhode Island College of Pharmacy, and hospitals including Rhode Island Hospital and Hasbro Children's Hospital. Administrative oversight coordinates with the Rhode Island Department of Health, the Rhode Island Department of Behavioral Healthcare, Developmental Disabilities and Hospitals, and state licensing divisions, while advisory liaisons interact with federated bodies like National Association of Boards of Pharmacy, American Pharmacists Association, American Society of Health-System Pharmacists, Pharmacy Technician Certification Board, and Board of Pharmacy Specialties.
Licensure pathways mirror standards put forth by National Association of Boards of Pharmacy and educational accreditation by Accreditation Council for Pharmacy Education. The board issues pharmacist licenses, intern registrations, pharmacy technician credentials, and facility permits for community pharmacies, hospital pharmacies, long-term care pharmacies such as those affiliated with Lifespan (health system), and specialty compounding pharmacies linked to compendia like United States Pharmacopeia. Rules incorporate requirements found in statutes such as those modeled on the Controlled Substances Act and integrate examinations like the North American Pharmacist Licensure Examination and certifications from Pharmacy Technician Certification Board. Continuing licensure considerations reflect guidance from Centers for Medicare & Medicaid Services and inspection data used by accrediting organizations like The Joint Commission.
Inspection protocols are executed by investigators collaborating with agencies such as the Drug Enforcement Administration, Federal Bureau of Investigation, Office of Inspector General (United States Department of Health and Human Services), and state entities including the Rhode Island Attorney General. Enforcement actions range from fines and consent agreements to license suspension and revocation pursued through administrative hearings before bodies akin to the Rhode Island Superior Court or administrative tribunals. The board’s disciplinary docket considers evidence from pharmacy practice audits, controlled-substance diversion investigations involving law enforcement task forces, and reports from professional societies like American Society of Health-System Pharmacists and National Community Pharmacists Association.
Policy on controlled substances dovetails with federal frameworks established by the Drug Enforcement Administration and state statutes influenced by national initiatives like the CDC Guideline for Prescribing Opioids for Chronic Pain and programs such as Prescription Drug Monitoring Program networks. The board oversees implementation of the statewide prescription monitoring system interoperable with neighboring PDMPs in Massachusetts, Connecticut, and New Hampshire, coordinates data submission by pharmacies associated with chains such as CVS Pharmacy, Walgreens, Rite Aid, and hospital systems like Care New England, and sets rules for dispensing, inventory controls, and theft reporting per standards promoted by United States Pharmacopeia and litigation precedents in federal courts.
Standards for professional conduct and continuing education reflect accreditation and curricular influences from Accreditation Council for Pharmacy Education, training programs at University of Rhode Island College of Pharmacy, postgraduate residencies accredited by American Society of Health-System Pharmacists, and certification bodies including Board of Pharmacy Specialties. Mandatory continuing education requirements are coordinated with providers such as American Pharmacists Association, specialty organizations like International Academy of Compounding Pharmacists, and employer systems including Lifespan (health system), with content addressing topics from immunization protocols endorsed by Centers for Disease Control and Prevention to sterile compounding standards guided by United States Pharmacopeia chapters.
The board provides public-facing services including complaint intake, license verification, and consumer advisories working alongside Rhode Island Department of Health, Rhode Island Attorney General, and patient advocacy groups such as AARP and local chapters of United Way of Rhode Island. Public safety initiatives coordinate with immunization campaigns involving Centers for Disease Control and Prevention, opioid overdose prevention efforts with Substance Abuse and Mental Health Services Administration, and medication take-back events in collaboration with law enforcement partners like the Rhode Island State Police. The board issues guidance on recalls tied to manufacturers like Pfizer, Johnson & Johnson, Bristol-Myers Squibb, and life science regulators such as the Food and Drug Administration to protect consumers and maintain supply chain integrity involving wholesalers, distributors, and pharmacies across the state.
Category:Pharmacy in Rhode Island Category:State agencies of Rhode Island Category:Health regulation in the United States